CTNNB1 and neoplasm: Furthermore, metabolomic changes have been described in tumor cells to lead to an immunosuppressive microenvironment, such as one involving glutamine uptake and catabolism [29,30] or the exclusion of T-cells via the upregulation of beta-catenin in tumor cells [31].